Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin J Solomon

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
The New England Journal of Medicine|February 19, 2015
First-line crizotinib in ALK-positive lung cancerBenjamin J Solomon, Tony Mok
International Journal of Radiation Oncology, Biology, Physics|June 3, 2023
Metastatic Ablation in Epidermal Growth Factor Receptor Mutated Oligometastatic Non-Small Cell Lung Cancer-Upfront or Outback After Systemic Tyrosine Kinase Inhibitors?Shankar Siva, Benjamin J Solomon
Translational Lung Cancer Research|March 10, 2023
Optimal first-line treatment for metastatic ALK+ non-small cell lung cancer-a narrative reviewGrace Chazan, Benjamin J Solomon
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2025
Based on the CROWN Findings, Lorlatinib Should Be the Preferred First-Line Treatment for Patients With Advanced ALK-Positive NSCLCHui Jing Hoe, Benjamin J Solomon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2023
Optimizing Dosing of Trastuzumab Deruxtecan in <i>HER2</i>-Mutant Non-Small-Cell Lung Cancer: A Reminder That More Is Not Always BetterHui Jing Hoe, Benjamin J Solomon
Cancer|April 2, 2025
Treatment of non-small cell lung cancer with RET rearrangementsHui Jing Hoe, Benjamin J Solomon
Current Opinion in Oncology|December 20, 2017
Treatment of ALK-positive nonsmall cell lung cancer: recent advancesAlesha A Thai, Benjamin J Solomon
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 29, 2020
Reply to "Emergence of High Level of MET Amplification During Treatment With Selpercatinib in KIF5B-RET NSCLC"Jessica J Lin, Benjamin J Solomon
The New England Journal of Medicine|February 12, 2015
Crizotinib in ROS1-rearranged non-small-cell lung cancerAlice T Shaw, Benjamin J Solomon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2020
Immunotherapy for Anaplastic Thyroid CarcinomaAnnette M Lim, Benjamin J Solomon
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|February 19, 2015
First-line crizotinib in ALK-positive lung cancerBenjamin J Solomon, Tony Mok
International Journal of Radiation Oncology, Biology, Physics|June 3, 2023
Metastatic Ablation in Epidermal Growth Factor Receptor Mutated Oligometastatic Non-Small Cell Lung Cancer-Upfront or Outback After Systemic Tyrosine Kinase Inhibitors?Shankar Siva, Benjamin J Solomon
Translational Lung Cancer Research|March 10, 2023
Optimal first-line treatment for metastatic ALK+ non-small cell lung cancer-a narrative reviewGrace Chazan, Benjamin J Solomon
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2025
Based on the CROWN Findings, Lorlatinib Should Be the Preferred First-Line Treatment for Patients With Advanced ALK-Positive NSCLCHui Jing Hoe, Benjamin J Solomon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2023
Optimizing Dosing of Trastuzumab Deruxtecan in <i>HER2</i>-Mutant Non-Small-Cell Lung Cancer: A Reminder That More Is Not Always BetterHui Jing Hoe, Benjamin J Solomon
Cancer|April 2, 2025
Treatment of non-small cell lung cancer with RET rearrangementsHui Jing Hoe, Benjamin J Solomon
Current Opinion in Oncology|December 20, 2017
Treatment of ALK-positive nonsmall cell lung cancer: recent advancesAlesha A Thai, Benjamin J Solomon
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 29, 2020
Reply to "Emergence of High Level of MET Amplification During Treatment With Selpercatinib in KIF5B-RET NSCLC"Jessica J Lin, Benjamin J Solomon
The New England Journal of Medicine|February 12, 2015
Crizotinib in ROS1-rearranged non-small-cell lung cancerAlice T Shaw, Benjamin J Solomon
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2020
Immunotherapy for Anaplastic Thyroid CarcinomaAnnette M Lim, Benjamin J Solomon
Pageof 13